CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Lung Low Dose RadiationWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.13
D011014 Pneumonia NIH 0.06

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials


1 Phase II Study of Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis

The administration of low-dose lung irradiation produces anti-inflammatory effects that will decrease the pulmonary inflammatory response. The present study will evaluate the efficacy of treatment with low-dose pulmonary radiotherapy added to standard support therapy, in hospitalized patients with respiratory symptoms due to COVID-19 pneumonia, who do not experience improvement with conventional medical therapy and are not subsidiaries of ICU

NCT04414293 COVID Pneumonia, Viral Radiation: Lung Low Dose Radiation
MeSH:Pneumonia, Viral Pneumonia
HPO:Pneumonia

Primary Outcomes

Description: Clinical improvement of respiratory symptoms due to COVID-19 pneumonia after the treatment, measured as blood oxygen saturation levels

Measure: blood oxygen saturation level

Time: 48 hours

Description: radiological improvement of respiratory symptoms due to COVID-19 pneumonia after the treatment.

Measure: Torax X-ray

Time: 48 hours

Secondary Outcomes

Description: number of days of hospital stay.

Measure: Hospitalization

Time: 2 months

Description: Number of days free of assisted mechanical respiration.

Measure: days free of assisted mechanical respiration

Time: 3 month

Description: number of deaths

Measure: Mortality

Time: 3 months


Related HPO nodes (Using clinical trials)